pubrio
BioNTech SE logo

BioNTech SE

Privately Held
biontech.com
バイオテクノロジー研究5,000+ employeesFounded 2008🇩🇪 ドイツ

Biopharmaceutical New Technologies (BioNTech) is a global biotechnology company aspiring to translate science into survival by developing new immunotherapies utilizing the full potential of the immune system to fight cancer and infectious diseases. BioNTech is headquartered in Mainz, Germany, and operates globally with almost 7.000 pioneers. Our work is powered by one mission: Improving the health of people worldwide. We believe that scientific rigor and passion are the driving forces that are essential for innovative progress. BioNTech was founded in 2008 by scientists and physicians to translate science into survival by combining fundamental research and operational excellence. At BioNTech, we have been conducting fundamental research of mRNA technologies in the field of individualized cancer medicine for more than a decade. Some of our colleagues, including our co-founders, have been researching and developing mRNA-based vaccines for more than 25 years. Ready to join us on this journey? Explore the opportunities and become part of a team that aspires to turn bold ideas into real-world solutions: https://www.biontech.com/int/en/home/careers.html 🔗 Privacy Statement: https://www.biontech.com/int/en/home/data-privacy-statement.html 🔗 Imprint: https://www.biontech.com/int/en/home/imprint.html

設立年
2008
従業員数
5,000+
業種
バイオテクノロジー研究
企業タイプ
Privately Held
株式
nasdaq: BNTX
本社
🇩🇪Mainz, Rhineland-Palatinate (+6)
専門分野
製薬バイオテクノロジー医療バイオテクノロジー研究

拡大インテリジェンス

NEW · Pubrio 限定

BioNTech SE の市場拡大を追跡しています

グローバル展開

ライブ
ステージ
検討中投資中参入中稼働中

アクティビティパルス

新しいパートナーシップのアクティビティ — 2 件の新規シグナルが出現しました。

過去 90 日間
採用
12
採用
マーケティング・PR
0
アクティビティなし
プロダクト・技術
2終了
製品ローンチ
+2さらにカテゴリロック中
5件中3件を表示
知っておきたい情報

BioNTech SE に関するよくある質問

BioNTech SE の事業、市場、成長シグナルに関する簡潔な回答。

Biopharmaceutical New Technologies (BioNTech) is a global biotechnology company aspiring to translate science into survival by developing new immunotherapies utilizing the full potential of the immune system to fight cancer and infectious diseases. BioNTech is headquartered in Mainz, Germany, and operates globally with almost 7.000 pioneers. Our work is powered by one mission: Improving the health of people worldwide. We believe that scientific rigor and passion are the driving forces that are essential for innovative progress. BioNTech was founded in 2008 by scientists and physicians to translate science into survival by combining fundamental research and operational excellence. At BioNTech, we have been conducting fundamental research of mRNA technologies in the field of individualized cancer medicine for more than a decade. Some of our colleagues, including our co-founders, have been researching and developing mRNA-based vaccines for more than 25 years. Ready to join us on this journey? Explore the opportunities and become part of a team that aspires to turn bold ideas into real-world solutions: https://www.biontech.com/int/en/home/careers.html 🔗 Privacy Statement: https://www.biontech.com/int/en/home/data-privacy-statement.html 🔗 Imprint: https://www.biontech.com/int/en/home/imprint.html

今日から旅を始めましょう

まずはプラットフォームでも、まずは会話からでも

Pubrio を自分で使うことも、リサーチ・リード獲得・データ連携を私たちに任せることもできます。

チームに相談
Start Journey Image
pubrio

Pubrio は 50 以上のローカルソースからビジネス・人物・インテントデータを統合し、AI と収益チームに市場全体の可視性を提供します。

© 2026 Pubrio. 無断転載を禁じます。